Xiang-Qian Kong (Xiangqian Kong)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Circulating Tumor Cells

Capillary Electrophoresis

Epidermal Growth Factor Receptor

Top Venues

ACS chemical biology

Organic letters

Cancer research

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Huimin Zhang, Dounan Xu, Hongchan Huang, Hao Jiang, Linghao Hu, Liping Liu, Ge Sun, Jing Gao, Yuanqing Li, Cuicui Xia, Shijie Chen, Hu Zhou, Xiang-Qian Kong, Mingliang Wang, Cheng Luo
Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase. ACS chemical biology (2024)
Huimin Zhang, Dounan Xu, Hongchan Huang, Hao Jiang, Linghao Hu, Liping Liu, Ge Sun, Jing Gao, Yuanqing Li, Cuicui Xia, Shijie Chen, Hu Zhou, Xiang-Qian Kong, Mingliang Wang, Cheng Luo
Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase. ACS chemical biology 19 (4) (2024)
Huimin Zhang, Dounan Xu, Hongchan Huang, Hao Jiang, Linghao Hu, Liping Liu, Ge Sun, Jing Gao, Yuanqing Li, Cuicui Xia, Shijie Chen, Hu Zhou, Xiang-Qian Kong, Mingliang Wang, Cheng Luo
Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase. ACS chemical biology 19 (4) (2024)
Huimin Zhang, Dounan Xu, Hongchan Huang, Hao Jiang, Linghao Hu, Liping Liu, Ge Sun, Jing Gao, Yuanqing Li, Cuicui Xia, Shijie Chen, Hu Zhou, Xiang-Qian Kong, Mingliang Wang, Cheng Luo
Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase. ACS chemical biology 19 (4) (2024)
Huimin Zhang, Dounan Xu, Hongchan Huang, Hao Jiang, Linghao Hu, Liping Liu, Ge Sun, Jing Gao, Yuanqing Li, Cuicui Xia, Shijie Chen, Hu Zhou, Xiang-Qian Kong, Mingliang Wang, Cheng Luo
Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase. ACS chemical biology 19 (4) (2024)
Yingjie Chang, Huahui Guo, Xue Li, Liangyi Zong, Jiale Wei, Zhihai Li, Cheng Luo, Xinying Yang, Hao Fang, Xiang-Qian Kong, Xuben Hou
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity. Journal of medicinal chemistry (2024)
Xian-Zhe Fan, Jia-Qi Song, Li-Jun Zhang, Rong Wang, Ting Liu, Wen-Jing Bai, Xiang-Qian Kong, Ya-Si Huang, Hong Liang, Hai-Bing Liao
Picrachinentins A-F, 14-Membered Cyclopeptide Alkaloid-Type Burpitides with Uncommon N-Terminal Modifications from Picrasma chinensis and Their Neuroprotective Activity. Organic letters 26 (22) (2024)
Xian-Zhe Fan, Jia-Qi Song, Li-Jun Zhang, Rong Wang, Ting Liu, Wen-Jing Bai, Xiang-Qian Kong, Ya-Si Huang, Hong Liang, Hai-Bing Liao
Picrachinentins A-F, 14-Membered Cyclopeptide Alkaloid-Type Burpitides with Uncommon N-Terminal Modifications from Picrasma chinensis and Their Neuroprotective Activity. Organic letters (2024)
Hongru Tao, Chen Jin, Liyuan Zhou, Zhenzhong Deng, Xiao Li, Wenzhen Dang, Shijie Fan, Bing Li, Fei Ye, JunYan Lu, Xiang-Qian Kong, Chuanpeng Liu, Cheng Luo, Yuanyuan Zhang
PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer research (2023)